Thank you so much.
This is a question that comes up more often to me, which highlights the lack of transparency. Otherwise, people would know a lot of answers to many questions.
I myself am still learning of some apparent conflicts of interest of the task force members. Again, this past Monday I learned that some members had stock in one of the big pharmas that was discussed and disclosed it as not a conflict of interest.
I think one major issue is that there was no independent review of the conflicts of interest that were declared. This committee started in July—the first meeting was the first week of July—and was not known publicly until several weeks after that. The members were not known until several weeks after that. Then the conflicts of interest were not known until several....
I'm just going to take one second. I want to apologize to Dr. Nemer. I did not mean to accuse her of not writing the text and everything. She has very good staff.
Thank you.